Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.07.25.605227

EFMouse: a Matlab toolbox to model electric fields in the mouse brain

Abstract

Research into the mechanisms underlying neuromodulation by tES using in-vivo animal models is key to overcoming experimental limitations in humans and essential to building a detailed understanding of the in-vivo consequences of tES. Insights from such animal models are needed to develop targeted and effective therapeutic applications of non-invasive brain stimulation in humans. The sheer difference in scale and geometry between animal models and the human brain contributes to the complexity of designing and interpreting animal studies. Here, we introduce EFMouse, a toolbox that extends previous approaches to model intracranial electric fields and generate predictions that can be tested with in-vivo recordings in mice. Novel functionality includes the ability to capture typical surgical approaches in the mouse (e.g., cranial recording windows), the placement of stimulation electrodes anywhere in or on the animal, and novel ways to report field predictions, including some refined measures of focality and direction homogeneity, and quantification based on regions defined in the Allen Mouse Brain Atlas. Although the EFMouse toolbox is generally applicable to planning and designing tES studies in mice, we illustrate its use by posing questions about transcranial direct current stimulation (tDCS) experiments with the goal of targeting the left visual cortex of the mouse. The EFMouse toolbox is publicly available at https://github.com/klabhub/EFMouse. Author summaryTranscranial electrical stimulation offers opportunities for studying brain activity and developing neuromodulation therapies. Even though this technique is used extensively in humans, understanding its neural consequences is still limited. Mouse models offer an opportunity to bridge this gap. However, major differences between human and mouse brains, such as brain size and cortical folding, pose a challenge to the design of appropriate stimulation protocols in mice. To address this, we developed EFMouse, an open-source computational toolbox that predicts intracranial electrical fields in the mouse brain during stimulation. This toolbox allows researchers to design experiments by simulating electrode arrangements and quantifying properties of the predicted electric field in specific brain regions. By doing so, EFMouse can guide the optimization of stimulation techniques to achieve targeted and reproducible effects. We illustrate its use by comparing a series of electrode arrangements, in terms of the strength, focality, and direction of their induced electric field. By making EFMouse publicly available, we hope to advance fundamental neuroscience research and the development of future clinical applications. HighlightsEFMouse is a novel, open-source, Matlab-based electric field simulator for the mouse brain. EFMouse quantifies induced field focality and homogeneity in regions of the Allen Mouse Brain Atlas. Montages with a return on the mouses back generate homogeneous fields perpendicular to the cortical surface. Montages with a small distance between stimulation and return electrodes on the mouses head can generate focal, but relatively weak fields.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sanchez-Romero, R., Akyuz, S., Krekelberg, B.. 2024-07-26. EFMouse: a Matlab toolbox to model electric fields in the mouse brain. https://doi.org/10.1101/2024.07.25.605227

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗